Primary Care Management of Myocarditis and Pericarditis After mRNA COVID-19 Vaccines

This event will provide GPs with guidance on the identification and management of myocarditis and pericarditis following mRNA vaccination.

Myocarditis (inflammation of cardiac muscle) and/or pericarditis (inflammation of pericardium) following mRNA COVID-19 vaccines is predominantly seen in younger males including adolescents up to 2 weeks following vaccination.

Guest speakers:

• Dr Scott Parsons – GP Clinical Editor, HealthPathways Melbourne
• A/Prof Nigel Crawford - Director SAFEVIC, Chair, ATAGI
• Dr Bryn Jones - Deputy Director of Cardiology, Royal Children’s Hospital

Learning outcomes:

1. Identification and assessment of myocarditis and pericarditis following mRNA COVID-19 Vaccination
2. Understanding management and referral guidelines

GPs in the Eastern Melbourne PHN and North Western Melbourne PHN catchments can access the Myocarditis and Pericarditis After mRNA COVID-19 Vaccines pathway on HealthPathways Melbourne. E-mail the team on info@healthpathwaysmelbourne.org.au to retrieve your automatic login.

Download the flyer.